Apyx Medical Projects FY26 Revenue Between $57.5M and $58.5M
APYX has more than doubled off its 52-week low of $0.755 on elevated volume (1.9× avg).
Summary
Apyx Medical Corp. has issued its financial outlook for Fiscal Year 2026, forecasting revenue to fall within the range of $57.5 million to $58.5 million. This guidance provides a forward-looking view of the company's expected performance, which is crucial for investors and analysts. While the timeline shows recent analyst projections for Q4 2025 earnings, this new information specifically addresses FY26 revenue, making it a distinct and material update. Traders will use this guidance to adjust their financial models and investment theses, assessing the company's growth prospects and potential valuation. Investors should monitor how this guidance compares to current market expectations and any subsequent revisions.
At the time of this announcement, APYX was trading at $3.60 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $140.7M. The 52-week trading range was $0.76 to $4.50. This news item was assessed with neutral market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.